Wednesday

22nd Feb 2017

UK big pharma loses EU court battle over cheaper drugs

UK pharmaceutical firms have been defeated in their attempt to put an end to British government incentives to doctors to supply patients with cheaper but equivalent medicines.

The European Court of Justice rejected a complaint by the Association of the British Pharmaceutical Industry (ABPI) that such National Health Service (NHS) schemes were not an illegal inducement under EU law.

Dear EUobserver reader

Subscribe now for unrestricted access to EUobserver.

Sign up for 30 days' free trial, no obligation. Full subscription only 15 € / month or 150 € / year.

  1. Unlimited access on desktop and mobile
  2. All premium articles, analysis, commentary and investigations
  3. EUobserver archives

EUobserver is the only independent news media covering EU affairs in Brussels and all 28 member states.

♡ We value your support.

If you already have an account click here to login.

  • UK health authorities are not seeking commercial advantage by the incentive scheme (Photo: Flickr)

In order to reduce public expenditure, the public health authorities in England and Wales introduced schemes providing doctors with financial incentives to prescribe cheap generic drugs rather than their more expensive patented counterparts.

A 2001 European directive relating to medicinal products prohibits "pecuniary advantages or benefits in kind" from being offered to doctors or pharmacists.

The bill aimed to prevent drug firms from offering incentives such as holidays, golf club memberships or other bonuses for prescribing their product, but in an attempted reversal of the legislation's original intention, the companies argued that rewards to medical practices acted in the same way.

But the court found that the directive was concerned primarily with the promotional activities carried out by the pharmaceutical industry and sought to prevent promotional practices that could push doctors to act more in line with their wallet than a patient's interest.

"By contrast, that prohibition does not apply to national public health authorities which ... do not pursue any profit-making or commercial aim," the court said in its ruling.

"Therefore, the financial incentive scheme examined, which forms part of such a policy, cannot be regarded as seeking the promotion of commercial promotion of medicinal products."

"No danger to public health can be established," the court concluded.

France's Macron issues Brexit warning

The centrist presidential candidate tells talented Britons to come to France and warns against giving the UK "undue advantages" after Brexit, in a speech in London.

French police raid Le Pen's party office

Officers raid the National Front headquarters near Paris over allegations that leader Marine Le Pen used fake EU parliament contracts to pay her personal staff.

Interview

The Armenia-Azerbaijan war: A refugee's story

The lynching of a woman in the Soviet Union in 1988 gives insight into why reconciliation remains so hard in the 30-year long war on Europe's eastern fringe.

France's Macron issues Brexit warning

The centrist presidential candidate tells talented Britons to come to France and warns against giving the UK "undue advantages" after Brexit, in a speech in London.

French police raid Le Pen's party office

Officers raid the National Front headquarters near Paris over allegations that leader Marine Le Pen used fake EU parliament contracts to pay her personal staff.

News in Brief

  1. Romanian parliament buries controversial corruption decree
  2. Dozens drown off Libyan coast
  3. EU ministers approve anti-tax avoidance directive
  4. Poland rejects EU criticism of court changes
  5. German nationalist leader met with Putin allies in Moscow
  6. German housing market overheated, says Bundesbank
  7. France invites three EU leaders for Versailles summit in March
  8. Greece agrees on new bailout reforms

Stakeholders' Highlights

  1. Counter BalanceTrans-Adriatic Pipeline Is a Major Risk for Banks, Warns New Analysis
  2. Martens CentreEU and US Migration Policies Compared: Join the Debate on February 28th
  3. Swedish EnterprisesTechnology and Data Flows - Shaping the Society of Tomorrow
  4. UNICEFNearly 1.4 Million Children at Risk of Death as Famine Looms Across Africa and Yemen
  5. Malta EU 2017End of Roaming Fees: Council Reaches Agreement on Wholesale Caps
  6. Nordic Council of MinistersNordic Innovation House Opens in New York to Help Startups Access US Market
  7. Centre Maurits CoppietersMinorities and Migrations
  8. Salzburg Global SeminarThe Child in the City: Health, Parks and Play
  9. UNICEFNumber of Ukrainian Children Needing Aid Nearly Doubles to 1 Million Over the Past Year
  10. Centre Maurits CoppietersThe Situation of Refugee Women in Europe
  11. Salzburg Global SeminarToward a Shared Culture of Health: Charting the Patient-Clinician Relationship
  12. European Free AllianceAustria Should Preserve & Promote Bilingual and Multinational Carinthia